Endometrial hyperplasia: without atypia and with atypia
The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Berlin A.V.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5720f9cf9c2e46548e80c415663b46ec |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5720f9cf9c2e46548e80c415663b46ec2021-12-02T19:22:24ZEndometrial hyperplasia: without atypia and with atypia2079-56962079-583110.26442/20795696.2021.1.200666https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec2021-03-01T00:00:00Zhttps://gynecology.orscience.ru/2079-5831/article/viewFile/63625/46623https://doaj.org/toc/2079-5696https://doaj.org/toc/2079-5831The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification.Maksim A. SabantsevSvetlana V. ShramkoVladimir G. LevchenkoOleg A. VolkovTatyana V. TretyakovaIP Berlin A.V. articleadenomatosisendometrial cancerendometrial hyperplasiaglandular intraepithelial neoplasiahysteroscopypredictors of endometrial cancerreproducibility of the diagnosistamoxifenGynecology and obstetricsRG1-991RUГинекология, Vol 23, Iss 1, Pp 18-24 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
adenomatosis endometrial cancer endometrial hyperplasia glandular intraepithelial neoplasia hysteroscopy predictors of endometrial cancer reproducibility of the diagnosis tamoxifen Gynecology and obstetrics RG1-991 |
spellingShingle |
adenomatosis endometrial cancer endometrial hyperplasia glandular intraepithelial neoplasia hysteroscopy predictors of endometrial cancer reproducibility of the diagnosis tamoxifen Gynecology and obstetrics RG1-991 Maksim A. Sabantsev Svetlana V. Shramko Vladimir G. Levchenko Oleg A. Volkov Tatyana V. Tretyakova Endometrial hyperplasia: without atypia and with atypia |
description |
The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification. |
format |
article |
author |
Maksim A. Sabantsev Svetlana V. Shramko Vladimir G. Levchenko Oleg A. Volkov Tatyana V. Tretyakova |
author_facet |
Maksim A. Sabantsev Svetlana V. Shramko Vladimir G. Levchenko Oleg A. Volkov Tatyana V. Tretyakova |
author_sort |
Maksim A. Sabantsev |
title |
Endometrial hyperplasia: without atypia and with atypia |
title_short |
Endometrial hyperplasia: without atypia and with atypia |
title_full |
Endometrial hyperplasia: without atypia and with atypia |
title_fullStr |
Endometrial hyperplasia: without atypia and with atypia |
title_full_unstemmed |
Endometrial hyperplasia: without atypia and with atypia |
title_sort |
endometrial hyperplasia: without atypia and with atypia |
publisher |
IP Berlin A.V. |
publishDate |
2021 |
url |
https://doaj.org/article/5720f9cf9c2e46548e80c415663b46ec |
work_keys_str_mv |
AT maksimasabantsev endometrialhyperplasiawithoutatypiaandwithatypia AT svetlanavshramko endometrialhyperplasiawithoutatypiaandwithatypia AT vladimirglevchenko endometrialhyperplasiawithoutatypiaandwithatypia AT olegavolkov endometrialhyperplasiawithoutatypiaandwithatypia AT tatyanavtretyakova endometrialhyperplasiawithoutatypiaandwithatypia |
_version_ |
1718376736977059840 |